Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07205614

The Good Pain Consultation in Endometriosis.

This PhD project investigates the effect of "the good pain consultation" and early integration of biopsychosocial pain education with current standard management of endometriosis. Our goal is to facilitate self-management of pain and improve health-related quality of life (HRQOL) using limited resources.

Our research question is: Does a good pain consultation improve pain self-efficacy and HRQOL, compared to usual care at 3 months and 1 year.?

Researchers will compare a good pain consultation to a control group that will receive usual care.

Participants will:

Attend a consultation and biopsychososial pain education plus usual care or usual care alone.

They will answer questions in an internet-based questionnaires three times point during the study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Sorlandet Sykehus HF

Kristiansand, Agder, 4600, Norway

Location status: Recruiting

Location contact

Alexandra Christine Hott, phd

CONTACT

[email protected]

+47 38149348

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • biological women

Exclusion criteria

  • not speaking norwegian

Treatment and study plan

pain consultation, biopsychosocial pain education + usual care

Other

Participants will receive a link to a digital pain education program. The program will include standard information about endometriosis, but will also introduce a biopsychosocial understanding of pain including influence of psychological factors such as excessive worry, stress, sleep disturbance and emotional distress. Self-management strategies including physical activity, relaxation and breathing techniques, cognitive techniques, psychosocial support and appropriate use of pain medication and supplemental treatment (e.g. physical therapy, TENS, heat), will be introduced.

Participants will then attend a single "good pain consultation", a patient-centered consultation with a clinician associated with the project, in which content from the educational package will be reinforced. The consultation will provide the opportunity to address the biopsychosocial factors including anxiety, previous trauma, emotional distress etc. Shared decision-making regarding preferred self-management strat

Usual Care

Other

Usual follow up at the department of gynecology

Primary outcomes

  1. The Pain Self-Efficacy Questionaire

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    The Pain Self-Efficacy Questionnaire (PSEQ) is a 10 item self-report questionnaire which assesses confidence people with ongoing pain have in performing activities despite pain. Self-efficacy regarding household chores, socializing, work and coping without medication are assessed. Each item is scored on a 6-point scale, for a total raw score of 0-10 where high scores indicate greater levels of confidence in dealing with pain. The PSEQ is translated to Norwegian and used in previous Norwegian studies.

Secondary outcomes

  1. The Short Form-12/Rand 12 Health Survey

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    SF-12 is a tool for assessing HRQOL, encompassing eight health domains: physical functioning, role limitations due to physical and emotional problems, bodily pain, general health, vitality, social functioning, and mental health. These domains form two summary measures: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

  2. A single question about Quality of Life

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    They will be asked: "All in all, how satisfied are you with your life right now?" we are using a scale from 0 to 10, where 0 means not at all satisfied and 10 means very satisfied.

  3. Pain catastrophizing scale (PCS)

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    PCS measures pain catastrophizing and "exaggerated negative orientation toward pain stimuli and pain experience". The scale consists of 13 items and includes subscale scores for rumination, magnification and helplessness.

  4. The Hopkins Symptom Checklist (HSCL-10).

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    The Hopkins Symptom Checklist (HSCL-10) is assessing emotional distress. The HSCL-10 consists of 10 questions assessing symptoms of anxiety and depression (range 1 to 4, most symptoms). Scores ≥1.75 are indicative of increased emotional distress.

  5. Numeric rating scales (NRS)

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    Numeric rating scales (NRS) rating from 0 to 10 measuring pain intensity. 0 means no pain and 10 means worst possible pain. Three NRS measures will be done registering worst pain intensity and bothersomeness of pain, during the past month

  6. The Decreased Sexual Desire Screener (DSDS)

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    (DSDS) is a simple, validated diagnostic tool to help to identify and discuss hypoactive sexual dysfunction among women.

  7. The Brief Illness Perception Questionnaire (Brief IPQ)

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    Brief IPQ is used to assess the cognitive and emotional perception of their illness and consists of nine questions. Answers are scored on a Likert scale from 0-10 scale in the first eight question and the latter question has an open-ended respons. Higher scores indicate more threatening/negative views of their pelvic pain.

  8. 2016 Fibromyalgia diagnostic criteria

    Time frame: The participants will report the outcome measures at baseline, after 3 and after 12 months.

    The 2016 Fibromyalgia diagnostic criteria are used to identify fibromyalgia based on symptom severity and pain distribution. The criteria include two main components:

    • Widespread Pain Index (WPI), which Assess pain in 19 body regions over the past week with a Score range: 0-19 (1 point per painful area)
    • Symptom Severity Scale (SSS) measures severity (0-3) of fatigue, unrefreshing sleep, and cognitive symptoms with a score range: 0-12

    Diagnosis is met if: WPI ≥ 7 and SSS ≥ 5, or WPI 4-6 and SSS ≥ 9 and symptoms have been present at a similar level for at least 3 months, with generalized pain in at least 4 of 5 body regions

  9. Other questions

    Time frame: The participants will report the outcome measures at baseline and after 12 months.

    We will ask questions about sociodemographic factors, symptoms related to the condition, and how one lives with the condition. Additionally, medical record information regarding the current condition and comorbidity

  10. intention to reconsult and use of healthcare services

    Time frame: The participants will report the outcome measures at baseline and after 12 months

    Intention to re-consult, use of health care services and use of medication will be elicited. The partisipant will report this in questionaires, and data will also be collected from national registers.

Study contacts

Contact information is provided by the study sponsor or research team.

Alexandra Christine Hott, MD, PhD

CONTACT

[email protected]

+47 38149348

Inger Johanne W Hansen, MD

CONTACT

[email protected]

+47 38149424

Sponsors and collaborators

Lead sponsor

Sorlandet Hospital HF

Other Gov

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2028
First posted
Oct 3, 2025
Registry last updated
Apr 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.